As far as CBD is concerned, the results of a pharmacogenomics study by Volmar et al. provided interesting evidence showing that CBD converts NF-κB into a tumor suppressor in GBM with defined antioxidative properties. The gene discussed is NFKB1; the disease is neoplasm.